Doctor Tatsuya Yamaji
Kanonji (Japan)
Examination of the acute efficacy and safety about aggressive use of tolvaptan for early rising after admission in super-elder patients with congestive heart failure.
Event: ESC Congress 2021 - The Digital Experience
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic heart failure e-posters
ESC 365 is supported by
